HBIO - Harvard Bioscience, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5151.73M
Enterprise Value 3142.68M
Trailing P/E N/A
Forward P/E 124.17
PEG Ratio (5 yr expected) 13.35
Price/Sales (ttm)1.50
Price/Book (mrq)1.97
Enterprise Value/Revenue 31.41
Enterprise Value/EBITDA 645.95

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Sep 30, 2017

Profitability

Profit Margin -3.16%
Operating Margin (ttm)-0.70%

Management Effectiveness

Return on Assets (ttm)-0.40%
Return on Equity (ttm)-4.17%

Income Statement

Revenue (ttm)100.83M
Revenue Per Share (ttm)2.91
Quarterly Revenue Growth (yoy)0.20%
Gross Profit (ttm)48.41M
EBITDA 3.1M
Net Income Avi to Common (ttm)-3.18M
Diluted EPS (ttm)-0.09
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.84M
Total Cash Per Share (mrq)0.17
Total Debt (mrq)12.48M
Total Debt/Equity (mrq)16.23
Current Ratio (mrq)3.40
Book Value Per Share (mrq)2.20

Cash Flow Statement

Operating Cash Flow (ttm)3.72M
Levered Free Cash Flow (ttm)3.7M

Trading Information

Stock Price History

Beta 0.60
52-Week Change 325.81%
S&P500 52-Week Change 323.26%
52 Week High 34.50
52 Week Low 32.25
50-Day Moving Average 33.47
200-Day Moving Average 33.24

Share Statistics

Avg Vol (3 month) 360.05k
Avg Vol (10 day) 373.02k
Shares Outstanding 534.88M
Float 29.24M
% Held by Insiders 117.77%
% Held by Institutions 162.72%
Shares Short 3545.64k
Short Ratio 39.49
Short % of Float 31.68%
Shares Short (prior month) 3547.16k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21319/1000
Last Split Date 3Nov 4, 2013